Type I diabetes management is complex and multifaceted. The COVID-19 pandemic has added to the complexity of Type 1 diabetes (T1D) diagnosis and management. This article reviews the literature surrounding patient characteristics of those with a new diagnosis of Type 1 diabetes, including those with Diabetic Ketoacidosis (DKA), during the early phase of the pandemic
Type 1 diabetes mellitus (T1DM) is an endocrine disorder, marked by elevated blood glucose level cau...
BACKGROUND AND AIMS: We aimed to study newly diagnosed diabetes in patients with mild to moderate CO...
Fulminant type 1 diabetes (FT1D) is a subtype of type 1 diabetes (T1D) that is characterized by the ...
Aims: Recent evidence suggests a potential link between COVID-19 and type 1 diabetes (T1DM). The aim...
BACKGROUND: An increase in newly diagnosed type 1 diabetes (T1D) has been posited during the COVID-1...
A great global concern is currently focused on the coronavirus disease 2019 (COVID-19) pandemic and ...
Background: On March 11, 2020 the WHO announced a coronavirus disease 2019 (COVID-19) pandemic. Lock...
Due to the current COVID-19 pandemic, worldwide population's lifestyle has changed dramatically, cau...
The worldwide outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been an u...
Abstract Objective We conducted this study to investigate whether the COVID‐19 pandemic impacted the...
6noObjective: To evaluate whether the diagnosis of pediatric type 1 diabetes or its acute complicati...
Background. Coronavirus disease 2019 (COVID-19) is a viral infectious disease caused by severe acute...
Viral infections may increase the risk of developing type 1 diabetes (T1D), and recent reports sugge...
In the UK, there have been reports of significant reductions in paediatric emergency attendances and...
In March 2020, COVID-19 began spreading across the US. People with underlying health conditions, lik...
Type 1 diabetes mellitus (T1DM) is an endocrine disorder, marked by elevated blood glucose level cau...
BACKGROUND AND AIMS: We aimed to study newly diagnosed diabetes in patients with mild to moderate CO...
Fulminant type 1 diabetes (FT1D) is a subtype of type 1 diabetes (T1D) that is characterized by the ...
Aims: Recent evidence suggests a potential link between COVID-19 and type 1 diabetes (T1DM). The aim...
BACKGROUND: An increase in newly diagnosed type 1 diabetes (T1D) has been posited during the COVID-1...
A great global concern is currently focused on the coronavirus disease 2019 (COVID-19) pandemic and ...
Background: On March 11, 2020 the WHO announced a coronavirus disease 2019 (COVID-19) pandemic. Lock...
Due to the current COVID-19 pandemic, worldwide population's lifestyle has changed dramatically, cau...
The worldwide outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been an u...
Abstract Objective We conducted this study to investigate whether the COVID‐19 pandemic impacted the...
6noObjective: To evaluate whether the diagnosis of pediatric type 1 diabetes or its acute complicati...
Background. Coronavirus disease 2019 (COVID-19) is a viral infectious disease caused by severe acute...
Viral infections may increase the risk of developing type 1 diabetes (T1D), and recent reports sugge...
In the UK, there have been reports of significant reductions in paediatric emergency attendances and...
In March 2020, COVID-19 began spreading across the US. People with underlying health conditions, lik...
Type 1 diabetes mellitus (T1DM) is an endocrine disorder, marked by elevated blood glucose level cau...
BACKGROUND AND AIMS: We aimed to study newly diagnosed diabetes in patients with mild to moderate CO...
Fulminant type 1 diabetes (FT1D) is a subtype of type 1 diabetes (T1D) that is characterized by the ...